Patents by Inventor Tobias Fuchs

Tobias Fuchs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240194399
    Abstract: An induction charging device is disclosed. The induction charging device includes at least one coil and at least two magnetic-flux guiding elements spaced apart from one another. At least one gap is disposed between the at least two magnetic-flux guiding elements. A filling assembly is at least partially arranged in the at least one gap. The filling assembly is at least partly magnetically conductive. The filling assembly includes a plurality of layers where at least one layer defines a magnetically conductive layer and at least one other layer defines a magnetically neutral layer. The at least one gap has a gap height, a gap width, and a gap length. The filling assembly, in the at least one gap, is defined of different layers with respect to at least one of the gap height and the gap length.
    Type: Application
    Filed: February 10, 2021
    Publication date: June 13, 2024
    Inventors: Mike Boettigheimer, Tobias Fuchs, Christopher Laemmle, Timo Laemmle, Holger Schroth
  • Patent number: 11833523
    Abstract: In consideration of increasing throughput rate of a stable operating process as well as making the process energy-efficient, the aim is to optimise a fluidised bed opposed jet mill and a dedicated process to produce ultrafine particles from a feed material of low bulk density with a housing in vertical design, with a product feed point and a product discharge, with a grinding zone located in the lower area of the housing which has grinding nozzles spaced evenly around the circumference whose jets intersect at one central point and with a classifying device installed in the upper area of the housing. This is achieved by the feed material dosed to the mill from the bottom into the mill sump as a gas-particle mixture, whereby a deflector hood is located above the feed point and below the grinding nozzle level, and the grinding gas nozzles designed to be flush with the walls.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: December 5, 2023
    Assignee: HOSOKAWA ALPINE Aktiengesellschaft
    Inventors: Tobias Fuchs, Michael Müller, Bernhard Renner
  • Patent number: 11464833
    Abstract: The present invention relates to the treatment of tissue adhesions, e.g. tissue adhesions that occur after surgical interventions. More specifically, the invention refers to an enzyme having DNAse activity for use in a method of treating or preventing tissue adhesions. The invention also relates to a pharmaceutical composition that comprises an enzyme having DNAse activity for use in a method of treating or preventing tissue adhesions.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: October 11, 2022
    Assignee: NEUTROLIS, INC.
    Inventors: Michael Boettcher, Tobias Fuchs
  • Publication number: 20220132817
    Abstract: The present invention relates to a non-human mammalian animal which has been modified to have in the blood, plasma and/or serum (a) an increased number of leukocytes and/or neutrophils, and (b) a reduced activity of the DNase 1 and/or DNase 1-like 3 enzymes. The non-human mammalian animal is particularly suitable for studying inflammation and/or a disease associated with inflammation. In a further aspect, the invention relates to the use of the non-human mammalian animal as a model for identifying therapeutic or diagnostic targets of inflammation and/or a disease associated with inflammation. In a still further aspect, the invention relates the use of the non-human mammalian animal as a model for drug candidate testing. In addition, a method for testing an anti-inflammatory drug candidate against extracellular DNA is provided. Finally, a method for testing an anti-inflammatory drug candidate for modifying the formation or degradation of neutrophil extracellular traps is provided.
    Type: Application
    Filed: January 10, 2022
    Publication date: May 5, 2022
    Inventors: Tobias FUCHS, Miguel JIMENEZ-ALCAZAR, Chandini RANGASWAMY
  • Publication number: 20220105520
    Abstract: In consideration of increasing throughput rate of a stable operating process as well as making the process energy-efficient, the aim is to optimise a fluidised bed opposed jet mill and a dedicated process to produce ultrafine particles from a feed material of low bulk density with a housing in vertical design, with a product feed point and a product discharge, with a grinding zone located in the lower area of the housing which has grinding nozzles spaced evenly around the circumference whose jets intersect at one central point and with a classifying device installed in the upper area of the housing. This is achieved by the feed material dosed to the mill from the bottom into the mill sump as a gas-particle mixture, whereby a deflector hood is located above the feed point and below the grinding nozzle level, and the grinding gas nozzles designed to be flush with the walls.
    Type: Application
    Filed: September 30, 2021
    Publication date: April 7, 2022
    Applicant: HOSOKAWA ALPINE Aktiengesellschaft
    Inventors: Tobias FUCHS, Michael MÜLLER, Bernhard RENNER
  • Publication number: 20190374620
    Abstract: The present invention relates to the treatment of tissue adhesions, e.g. tissue adhesions that occur after surgical interventions. More specifically, the invention refers to an enzyme having DNAse activity for use in a method of treating or preventing tissue adhesions. The invention also relates to a pharmaceutical composition that comprises an enzyme having DNAse activity for use in a method of treating or preventing tissue adhesions.
    Type: Application
    Filed: January 22, 2018
    Publication date: December 12, 2019
    Inventors: Michael BOETTCHER, Tobias FUCHS
  • Publication number: 20190350178
    Abstract: The present invention relates to a non-human mammalian animal which has been modified to have in the blood, plasma and/or serum (a) an increased number of leukocytes and/or neutrophils, and (b) a reduced activity of the DNase 1 and/or DNase 1-like 3 enzymes. The non-human mammalian animal is particularly suitable for studying inflammation and/or a disease associated with inflammation. In a further aspect, the invention relates to the use of the non-human mammalian animal as a model for identifying therapeutic or diagnostic targets of inflammation and/or a disease associated with inflammation. In a still further aspect, the invention relates the use of the non-human mammalian animal as a model for drug candidate testing. In addition, a method for testing an anti-inflammatory drug candidate against extracellular DNA is provided. Finally, a method for testing an anti-inflammatory drug candidate for modifying the formation or degradation of neutrophil extracellular traps is provided.
    Type: Application
    Filed: January 22, 2018
    Publication date: November 21, 2019
    Inventors: Tobias FUCHS, Miguel JIMENEZ-ALCAZAR, Chandini RANGASWAMY
  • Patent number: 10468575
    Abstract: A thermoelectric module may include a fluid-tight housing having at least one thermoelectrically active element arranged therein. The at least one thermoelectrically active element may have a coating. The housing may form an outer encapsulation and the coating may form an inner encapsulation for the at least one thermoelectrically active element.
    Type: Grant
    Filed: February 19, 2014
    Date of Patent: November 5, 2019
    Assignee: Mahle Behr GmbH & Co. KG
    Inventors: Hans-Heinrich Angermann, Tobias Fuchs, Thomas Himmer, Volker Schall
  • Publication number: 20190234936
    Abstract: The invention relates to immunodiagnostic detection of anti-neutrophil antibodies. Object of the current invention is to improve the diagnosis of ANCA-associated diseases, in particular ANCA-associated vasculitides.
    Type: Application
    Filed: July 20, 2017
    Publication date: August 1, 2019
    Inventor: Tobias FUCHS
  • Patent number: 8875502
    Abstract: An SCR exhaust gas aftertreatment device in which a urea-water solution is injected into an exhaust gas line is provided. At least one component of the device (e.g., a filter element) lies in an area of an internal space, and is bounded by an elastomer membrane that is embedded in a frost equalization foam. This prevents freezing damage even over a very long period of time and a large number of freezing cycles.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: November 4, 2014
    Assignee: Cummins Ltd.
    Inventors: Tobias Fuchs, Andreas Lannig, Ralf Rohrmueller, Sebastian Weidner, Friedrich Zapf
  • Publication number: 20140230875
    Abstract: A thermoelectric module may include a fluid-tight housing having at least one thermoelectrically active element arranged therein. The at least one thermoelectrically active element may have a coating. The housing may form an outer encapsulation and the coating may form an inner encapsulation for the at least one thermoelectrically active element.
    Type: Application
    Filed: February 19, 2014
    Publication date: August 21, 2014
    Applicant: Mahle Behr GmbH & Co. KG
    Inventors: Hans-Heinrich Angermann, Tobias Fuchs, Thomas Himmer, Volker Schall
  • Publication number: 20120144808
    Abstract: An SCR exhaust gas aftertreatment device in which a urea-water solution is injected into an exhaust gas line is provided. At least one component of the device (e.g., a filter element) lies in an area of an internal space, and is bounded by an elastomer membrane that is embedded in a frost equalization foam. This prevents freezing damage even over a very long period of time and a large number of freezing cycles.
    Type: Application
    Filed: December 12, 2011
    Publication date: June 14, 2012
    Applicant: Hilite Germany GmbH
    Inventors: Tobias Fuchs, Andreas Lannig, Ralf Rohrmueller, Sebastian Weidner, Friedrich Zapf